Cambridge Technologies

Cambridge Technologies is an independent, custom vaccine provider dedicated to serving veterinarians and livestock producers. The company specializes in developing autogenous vaccines, which are tailored to specific pathogens affecting livestock. Their offerings include precision vaccinology, combining next-generation diagnostics with quality custom manufacturing. Cambridge Technologies is committed to advancing animal health through innovative solutions and has recently expanded to manufacture and distribute autogenous vaccines in Canada.

Cambridge Technologies has achieved significant milestones, including the approval to manufacture and distribute autogenous vaccines to veterinarians in Canada. They have also introduced SoliDose®, a dual-dose autogenous vaccine implant delivery system designed for immediate and programmed release. These advancements underscore their impact on the veterinary and livestock industry, providing customized and effective solutions to enhance animal health and productivity.